Centene Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 5/6
Centene verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 17.3%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 5.3%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 13.3%. Die Eigenkapitalrendite von Centene beträgt 11.1% und die Nettomargen betragen 2.1%.
Wichtige Informationen
17.3%
Wachstumsrate der Gewinne
14.4%
EPS-Wachstumsrate
| Healthcare Wachstum der Industrie | 8.5% |
| Wachstumsrate der Einnahmen | 13.3% |
| Eigenkapitalrendite | 11.1% |
| Netto-Marge | 2.1% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Centene: Should Have Followed My Original Thesis, But A Buy For Q3 2024
Oct 22Centene Corporation (NYSE:CNC) Screens Well But There Might Be A Catch
Oct 14
Should You Be Adding Centene (NYSE:CNC) To Your Watchlist Today?
Sep 26Centene (NYSE:CNC) Has Some Way To Go To Become A Multi-Bagger
Sep 08Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Aug 20Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy
Aug 20Centene (NYSE:CNC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Aug 02Here's Why We Think Centene (NYSE:CNC) Is Well Worth Watching
Jun 22A Piece Of The Puzzle Missing From Centene Corporation's (NYSE:CNC) Share Price
Jun 04Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Aufschlüsselung der Einnahmen und Ausgaben
Wie Centene Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 146,204 | 3,067 | 12,507 | 0 |
| 30 Jun 24 | 144,064 | 2,823 | 12,455 | 0 |
| 31 Mar 24 | 142,800 | 2,735 | 12,573 | 0 |
| 31 Dec 23 | 141,266 | 2,702 | 12,407 | 0 |
| 30 Sep 23 | 139,364 | 2,444 | 12,130 | 0 |
| 30 Jun 23 | 138,111 | 2,713 | 11,934 | 0 |
| 31 Mar 23 | 136,941 | 1,483 | 11,704 | 0 |
| 31 Dec 22 | 135,999 | 1,202 | 11,366 | 0 |
| 30 Sep 22 | 132,756 | 2,014 | 10,892 | 0 |
| 30 Jun 22 | 129,228 | 1,860 | 10,562 | 0 |
| 31 Mar 22 | 124,181 | 1,497 | 9,888 | 0 |
| 31 Dec 21 | 118,573 | 1,347 | 9,376 | 0 |
| 30 Sep 21 | 114,130 | 736 | 9,657 | 0 |
| 30 Jun 21 | 111,284 | 720 | 9,995 | 0 |
| 31 Mar 21 | 108,158 | 2,461 | 10,461 | 0 |
| 31 Dec 20 | 104,280 | 1,808 | 10,276 | 0 |
| 30 Sep 20 | 95,764 | 2,029 | 9,529 | 0 |
| 30 Jun 20 | 86,523 | 1,556 | 8,301 | 0 |
| 31 Mar 20 | 78,105 | 845 | 7,290 | 0 |
| 31 Dec 19 | 70,807 | 1,321 | 6,448 | 0 |
| 30 Sep 19 | 68,385 | 1,353 | 6,472 | 0 |
| 30 Jun 19 | 65,507 | 1,277 | 6,591 | 0 |
| 31 Mar 19 | 61,028 | 1,082 | 6,457 | 0 |
| 31 Dec 18 | 56,688 | 900 | 6,331 | 0 |
| 30 Sep 18 | 52,618 | 889 | 5,795 | 0 |
| 30 Jun 18 | 48,655 | 1,075 | 5,105 | 0 |
| 31 Mar 18 | 47,201 | 1,029 | 4,797 | 0 |
| 31 Dec 17 | 45,810 | 828 | 4,370 | 0 |
| 30 Sep 17 | 44,870 | 853 | 4,267 | 0 |
| 30 Jun 17 | 43,646 | 796 | 4,303 | 0 |
| 31 Mar 17 | 42,468 | 713 | 4,246 | 0 |
| 31 Dec 16 | 37,693 | 562 | 3,900 | 0 |
| 30 Sep 16 | 32,839 | 416 | 3,284 | 0 |
| 30 Jun 16 | 28,062 | 360 | 2,719 | 0 |
| 31 Mar 16 | 22,948 | 277 | 2,152 | 0 |
| 31 Dec 15 | 21,292 | 356 | 1,990 | 0 |
| 30 Sep 15 | 19,854 | 350 | 1,827 | 0 |
| 30 Jun 15 | 18,548 | 339 | 1,699 | 0 |
| 31 Mar 15 | 17,102 | 298 | 1,564 | 0 |
| 31 Dec 14 | 15,689 | 268 | 1,424 | 0 |
| 30 Sep 14 | 14,134 | 210 | 1,300 | 0 |
| 30 Jun 14 | 12,700 | 179 | 1,183 | 0 |
| 31 Mar 14 | 11,475 | 172 | 1,055 | 0 |
| 31 Dec 13 | 10,544 | 161 | 931 | 0 |
Qualität der Erträge: CNC hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: CNCDie aktuellen Gewinnspannen (2.1%) sind höher als im letzten Jahr (1.8%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: CNCIn den letzten 5 Jahren sind die Gewinne von 17.3% jährlich gestiegen.
Beschleunigtes Wachstum: CNCDas Gewinnwachstum des Unternehmens im letzten Jahr (25.5%) übertrifft seinen 5-Jahres-Durchschnitt (17.3% pro Jahr).
Erträge im Vergleich zur Industrie: CNC Das Gewinnwachstum im vergangenen Jahr (25.5%) übertraf das der Branche Healthcare 10.3% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: CNCDie Eigenkapitalrendite des Unternehmens (11.1%) wird als niedrig angesehen.